Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
© 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.
Bibliographic Details
| Main Authors: |
Manu, K.,
Shanmugam, M.,
Ramachandran, L.,
Li, F.,
Siveen, K.,
Chinnathambi, A.,
Zayed, M.,
Alharbi, S.,
Arfuso, Frank,
Kumar, Alan Prem,
Ahn, K.,
Sethi, G. |
|---|
| Format: | Journal Article
|
|---|
| Published: |
Elsevier
2018
|
|---|
| Online Access: | http://hdl.handle.net/20.500.11937/67036
|
|---|